Edwards Lifesciences (EW) vs Stryker (SYK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Edwards Lifesciences (EW) has outperformed Stryker (SYK) over the past year, gaining 11.8% versus a loss of 24.7%. Over five years, SYK leads with a +4.3% price change compared with -23.5% for EW. Stryker is the larger company by market cap ($105.64 billion vs $49.44 billion), about 2.1 times the size, while Edwards Lifesciences is growing revenue faster (+11.5% vs +11.2%).
On valuation, Stryker trades at a lower forward P/E (16.5x vs 25.4x for Edwards Lifesciences). Stryker pays a dividend yielding 1.26%, while Edwards Lifesciences does not currently pay one. Edwards Lifesciences converts more of its revenue into profit, with a net margin of 17.7% versus 12.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EW | SYK |
|---|---|---|
| Share price | $85.78 | $275.40 |
| Market cap | $49.44B | $105.64B |
| 1-day change | -0.81% | -1.01% |
| YTD return | +0.62% | -20.93% |
| 1-year return | +11.81% | -24.74% |
| 5-year return | -23.52% | +4.34% |
| P/E ratio (TTM) | 51.06 | 28.84 |
| Forward P/E | 25.40 | 16.49 |
| EPS (TTM) | $1.68 | $9.55 |
| Dividend yield | 0.00% | 1.26% |
| Annual dividend | $0.00 | $3.48 |
| Revenue (latest FY) | $6.07B | $25.12B |
| Revenue growth (YoY) | +11.55% | +11.16% |
| Net income (latest FY) | $1.07B | $3.25B |
| Gross margin | 78.01% | 63.96% |
| Operating margin | 20.84% | 19.47% |
| Net margin | 17.69% | 12.92% |
| 52-week high | $96.29 | $392.55 |
| 52-week low | $72.30 | $267.00 |
| Distance from 52-week high | -10.91% | -29.84% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +18.86% | +32.95% |
| Average volume | 3.82M | 2.64M |
| Shares outstanding | 576.40M | 383.57M |
| Employees | 16,000 | 56,000 |
| Sector | Healthcare | Health Care |
| Industry | Medical Devices | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Stryker is about 2.1 times larger than Edwards Lifesciences by market value ($105.64B vs $49.44B).
- EW has outperformed SYK by 36.5 percentage points over the past year.
- Edwards Lifesciences trades at a higher earnings multiple (51.1x vs 28.8x trailing P/E).
- Stryker offers a meaningfully higher dividend yield (1.26% vs 0.00%).
- The two companies sit in different sectors: Edwards Lifesciences in Healthcare and Stryker in Health Care.
About Edwards Lifesciences
EW stock →Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands.
Healthcare · Medical Devices · 16,000 employees
About Stryker
SYK stock →Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.
Health Care · Medical/Dental Instruments · 56,000 employees
EW vs SYK FAQ
Which is bigger, Edwards Lifesciences or Stryker?
Stryker (SYK) is larger, with a market capitalization of $105.64B compared with $49.44B for Edwards Lifesciences (EW).
Which stock has performed better over the past year, EW or SYK?
EW returned +11.81% over the past 12 months, compared with -24.74% for SYK (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, EW or SYK?
SYK has the lower trailing P/E at 28.8, versus 51.1 for EW. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Edwards Lifesciences or Stryker?
Stryker pays a dividend yielding 1.26%, while Edwards Lifesciences does not currently pay a regular dividend.
Are Edwards Lifesciences and Stryker in the same industry?
No. Edwards Lifesciences is in the Healthcare sector, while Stryker is in Health Care.